FDC
|
FDC Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 11.70 | 12.82 | 17.85 | 14.03 | 9.74 |
CEPS(Rs) | 14.03 | 15.01 | 20.08 | 16.22 | 11.64 |
DPS(Rs) | - | - | - | 0.80 | - |
Book NAV/Share(Rs) | 119.47 | 115.92 | 102.73 | 90.51 | 82.86 |
Tax Rate(%) | 24.82 | 25.30 | 22.32 | 25.03 | 28.25 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 13.57 | 16.12 | 24.46 | 21.25 | 20.61 |
EBIT Margin(%) | 14.24 | 18.59 | 28.65 | 23.45 | 21.24 |
Pre Tax Margin(%) | 14.02 | 18.39 | 28.40 | 23.21 | 21.11 |
PAT Margin (%) | 10.54 | 13.74 | 22.06 | 17.40 | 15.15 |
Cash Profit Margin (%) | 12.66 | 16.11 | 24.83 | 20.12 | 18.11 |
Performance Ratios | |||||
ROA(%) | 6.23 | 7.59 | 11.85 | 10.43 | 8.20 |
ROE(%) | 9.84 | 11.71 | 18.36 | 16.03 | 12.48 |
ROCE(%) | 13.25 | 15.78 | 23.74 | 21.56 | 17.49 |
Asset Turnover(x) | 0.59 | 0.55 | 0.54 | 0.60 | 0.54 |
Sales/Fixed Asset(x) | 1.91 | 1.70 | 1.57 | 1.66 | 1.41 |
Working Capital/Sales(x) | 2.58 | 2.16 | 1.88 | 2.03 | 2.00 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.52 | 0.59 | 0.64 | 0.60 | 0.71 |
Receivable days | 20.32 | 22.35 | 31.31 | 27.96 | 27.55 |
Inventory Days | 62.83 | 60.27 | 56.79 | 50.80 | 54.43 |
Payable days | 87.78 | 73.73 | 86.01 | 83.79 | 92.50 |
Valuation Parameters | |||||
PER(x) | 21.94 | 20.04 | 16.00 | 13.97 | 17.21 |
PCE(x) | 18.29 | 17.11 | 14.23 | 12.08 | 14.39 |
Price/Book(x) | 2.15 | 2.22 | 2.78 | 2.17 | 2.02 |
Yield(%) | - | - | - | 0.41 | - |
EV/Net Sales(x) | 2.38 | 2.82 | 3.60 | 2.47 | 2.66 |
EV/Core EBITDA(x) | 14.09 | 13.06 | 11.13 | 9.19 | 10.57 |
EV/EBIT(x) | 16.19 | 14.72 | 12.27 | 10.28 | 12.18 |
EV/CE(x) | 1.33 | 1.42 | 1.81 | 1.37 | 1.34 |
M Cap / Sales | 2.39 | 2.84 | 3.62 | 2.49 | 2.68 |
Growth Ratio | |||||
Net Sales Growth(%) | 16.74 | 14.61 | -0.82 | 23.24 | 1.45 |
Core EBITDA Growth(%) | -8.78 | -23.50 | 19.14 | 31.83 | -1.14 |
EBIT Growth(%) | -10.46 | -25.23 | 20.96 | 35.83 | -1.64 |
PAT Growth(%) | -10.33 | -28.23 | 25.56 | 41.28 | -2.14 |
EPS Growth(%) | -8.77 | -28.19 | 27.23 | 44.11 | -2.14 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | - | - |
Current Ratio(x) | 1.98 | 2.05 | 2.17 | 2.21 | 2.13 |
Quick Ratio(x) | 1.53 | 1.61 | 1.82 | 1.83 | 1.78 |
Interest Cover(x) | 64.07 | 94.67 | 113.90 | 94.66 | 165.52 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹7,394.4 Cr | -1.3% | -11% | 71.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,766.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹111,102.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,958.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹99,939.6 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,104.2 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | -1.3% |
-11% |
71.9% |
SENSEX | -2.4% |
-1% |
21.3% |
You may also like the below Video Courses